Team-Based Connected Health to Improve Access and Outcomes in Atopic Dermatitis
基于团队的互联健康可改善特应性皮炎的可及性和结果
基本信息
- 批准号:10341132
- 负责人:
- 金额:$ 67.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-05 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptedAdultAffectAreaAtopic DermatitisCaringChildChildhoodChronicChronic DiseaseClinicalCommunicationConsultationsCost SavingsDermatologistDermatologyDimensionsDiseaseDisease modelEczemaEuropeanEvaluationFosteringGoalsHealthHealth Care CostsHealth Services AccessibilityImprove AccessIndividualInflammationInflammatoryIntelligenceLocationMeasuresMental DepressionModelingMorbidity - disease rateOffice VisitsOutcomePatient CarePatient-Focused OutcomesPatientsPersonsProviderPruritusQuality of lifeRandomizedRecommendationRecording of previous eventsRelapseResearchRural CommunityService delivery modelSeveritiesSeverity of illnessSkinSleep DeprivationSpecialistStructureTechnologyTestingTransportationUncertaintyUnited StatesVisitWait Timebasecare deliverycare providerscare seekingchronic inflammatory skinclinical imagingconnected healthcostdesigndifferences in accessfollow-upfoster carehealth care deliveryhealth related quality of lifeimprovedimproved outcomeindexinginnovationinstrumentmedical specialtiesonline carepatient orientedpreferencepsychosocialskin disorderunderserved community
项目摘要
PROJECT SUMMARY / ABSTRACT
Skin diseases account for 30% of all physician office visits. In the United States, access to dermatologists
remains a significant challenge for those in underserved or rural communities. To increase access to
specialists and improve patient outcomes, we will evaluate a team-based connected health (TCH) model that
enables structured asynchronous online interactions among patients, primary care providers (PCPs), and
dermatologists. The goal of TCH is to enable effective management of chronic skin diseases via high-quality
and efficient online care between providers and patients. TCH purports to bring direct and expedient specialist
care to patients and PCPs in a location-independent and asynchronous manner.
Specifically, TCH offers several ways that patients and providers can communicate online asynchronously to
manage skin diseases: (1) PCP-dermatologist, (2) patient-dermatologist, and (3) patient-PCP interactions. With
PCP-dermatologist interactions, PCPs can access dermatologists online asynchronously for consultations or to
request a dermatologist to assume care of patient’s skin disease. With patient-dermatologist interactions,
patients can upload clinical images and history online and obtain asynchronous evaluation and
recommendations from dermatologists directly. Finally, PCPs have the option of managing their patients’ skin
diseases online. Importantly, TCH applies efficient workflow that maximally supports providers and fosters
multi-directional, informed communication among patients, PCPs, and dermatologists.
To evaluate the impact of TCH, we use atopic dermatitis (AD) as a disease model. AD is a common, relapsing
inflammatory skin disease affecting 32 million individuals in the U.S. AD is characterized by intense itching and
red, scaly patches. It incurs significant morbidities and high healthcare costs. To address skin inflammation,
itch, and psychosocial consequences, PCPs and dermatologists need to adopt a team-based approach to
effectively manage all aspects of AD.
The primary goal of the proposed research is to test whether the online TCH model results in equivalent
improvements in disease severity and quality of life, provides better access to specialist care, and is cost-
saving as compared to usual in-person care in pediatric and adult patients with AD. Specifically, we will
conduct a pragmatic, cluster-randomized controlled equivalency trial and use validated measures to compare
AD disease severity, health-related quality of life, and access to care between TCH and in-person care. We will
also compare costs of the two healthcare delivery models from a societal perspective by conducting cost-
minimization and sensitivity analyses. This proposal evaluates a significant innovation in specialty-care delivery
that will likely result in improved patient outcomes, greater access to specialists, and cost savings. The study
findings will be highly impactful and have immense dissemination potential to the management of many other
chronic diseases.
项目概要/摘要
在美国,皮肤科医生就诊的病例中,皮肤病占 30%。
对于那些服务不足或农村社区的人来说,增加获得服务的机会仍然是一个重大挑战。
专家并改善患者治疗结果,我们将评估基于团队的互联健康 (TCH) 模型,该模型
实现患者、初级保健提供者 (PCP) 和患者之间的结构化异步在线交互
TCH 的目标是通过高质量的治疗来有效管理慢性皮肤病。
TCH 旨在为提供者和患者提供直接、便捷的在线护理。
以与位置无关的异步方式为患者和 PCP 提供护理。
具体来说,TCH 提供了多种方式,使患者和提供者可以异步在线交流
管理皮肤病:(1) PCP-皮肤科医生,(2) 患者-皮肤科医生,以及 (3) 患者-PCP 互动。
PCP 与皮肤科医生互动,PCP 可以异步在线访问皮肤科医生进行咨询或咨询
要求皮肤科医生负责治疗患者的皮肤病,通过患者与皮肤科医生的互动,
患者可以在线上传临床图像和病史并获得异步评估和
最后,PCP 可以直接根据皮肤科医生的建议来管理患者的皮肤。
重要的是,TCH 采用高效的工作流程,最大限度地支持提供者和培育。
患者、PCP 和皮肤科医生之间的多向、知情沟通。
为了评估 TCH 的影响,我们使用特应性皮炎 (AD) 作为一种常见的复发性疾病模型。
炎症性皮肤病在美国影响着 3200 万人。其特点是剧烈瘙痒和
红色、鳞状斑块会导致严重的发病率和高昂的医疗费用。
瘙痒和社会心理后果,PCP 和皮肤科医生需要采取基于团队的方法来解决
有效管理 AD 的各个方面。
本研究的主要目标是测试在线 TCH 模型的结果是否等效
改善疾病严重程度和生活质量,提供更好的专科护理机会,并且成本低廉
与儿科和成人 AD 患者的常规面对面护理相比,可以节省具体费用。
进行务实的整群随机对照等效试验,并使用经过验证的措施进行比较
AD 疾病的严重程度、与健康相关的生活质量以及在 TCH 和面对面护理之间获得护理的机会。
还通过进行成本评估,从社会角度比较两种医疗保健提供模式的成本
该提案评估了专业护理服务方面的重大创新。
这可能会改善患者的治疗效果、更多地接触专家并节省成本。
研究结果将产生巨大影响,并对许多其他管理人员具有巨大的传播潜力
慢性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
April W Armstrong其他文献
Janus-kinase inhibitors in dermatology: A review of their use in psoriasis, vitiligo, systemic lupus erythematosus, hidradenitis suppurativa, dermatomyositis, lichen planus, lichen planopilaris, sarcoidosis and graft-versus-host disease.
Janus激酶抑制剂在皮肤病学中的应用:综述其在银屑病、白癜风、系统性红斑狼疮、化脓性汗腺炎、皮肌炎、扁平苔藓、扁平苔藓、结节病和移植物抗宿主病中的应用。
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Margaret Y. Huang;April W Armstrong - 通讯作者:
April W Armstrong
Prevalence, Incidence, and Risk of Chronic Obstructive Pulmonary Disease Among Psoriasis Patients.
银屑病患者慢性阻塞性肺疾病的患病率、发病率和风险。
- DOI:
10.1016/j.rmed.2024.107729 - 发表时间:
2024 - 期刊:
- 影响因子:4.3
- 作者:
Lily Guo;Sara N Bilimoria;Robin Kikuchi;Audrey Hao;Hannah Tolson;Rebecca K Yamamoto;Kaviyon Sadrolashrafi;Danielle Yee;April W Armstrong - 通讯作者:
April W Armstrong
Shared decision-making in psoriasis care: Evaluation of how patients’ perception of clinicians’ delivery of care changes by age and sex
银屑病护理中的共同决策:评估患者对信徒提供护理的看法如何随年龄和性别而变化
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:3.7
- 作者:
Robin Kikuchi;Paige Kingston;Audrey Hao;Kaviyon Sadrolashrafi;Rebecca K Yamamoto;Hannah C Tolson;Sara N Bilimoria;Lily Guo;Danielle K Yee;Maria T Ochoa;April W Armstrong - 通讯作者:
April W Armstrong
April W Armstrong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('April W Armstrong', 18)}}的其他基金
Assessment of Treatment Satisfaction in Psoriasis
银屑病治疗满意度评估
- 批准号:
10657012 - 财政年份:2023
- 资助金额:
$ 67.61万 - 项目类别:
Team-Based Connected Health to Improve Access and Outcomes in Atopic Dermatitis
基于团队的互联健康可改善特应性皮炎的可及性和结果
- 批准号:
10552028 - 财政年份:2019
- 资助金额:
$ 67.61万 - 项目类别:
Patient-Centered Online Care Model for Follow-Up Management of Atopic Dermatitis
以患者为中心的特应性皮炎后续管理在线护理模式
- 批准号:
8507613 - 财政年份:2009
- 资助金额:
$ 67.61万 - 项目类别:
Patient-Centered Online Care Model for Follow-Up Management of Atopic Dermatitis
以患者为中心的特应性皮炎后续管理在线护理模式
- 批准号:
7941834 - 财政年份:2009
- 资助金额:
$ 67.61万 - 项目类别:
Patient-Centered Online Care Model for Follow-Up Management of Atopic Dermatitis
以患者为中心的特应性皮炎后续管理在线护理模式
- 批准号:
8107608 - 财政年份:2009
- 资助金额:
$ 67.61万 - 项目类别:
Patient-Centered Online Care Model for Follow-Up Management of Atopic Dermatitis
以患者为中心的特应性皮炎后续管理在线护理模式
- 批准号:
8791378 - 财政年份:2009
- 资助金额:
$ 67.61万 - 项目类别:
Patient-Centered Online Care Model for Follow-Up Management of Atopic Dermatitis
以患者为中心的特应性皮炎后续管理在线护理模式
- 批准号:
7781767 - 财政年份:2009
- 资助金额:
$ 67.61万 - 项目类别:
Patient-Centered Online Care Model for Follow-Up Management of Atopic Dermatitis
以患者为中心的特应性皮炎后续管理在线护理模式
- 批准号:
8298923 - 财政年份:2009
- 资助金额:
$ 67.61万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
中性粒细胞胞外诱捕网(NETs)通过AIM2炎症小体促进成人斯蒂尔病髓系细胞生成并放大细胞因子风暴的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DDX11突变通过激活P38MAPK/PI3K/Akt/CREB信号通路调控钙调蛋白结合蛋白促进成人AML复发的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多溴联苯醚通过肠道菌群诱导维汉成人2型糖尿病的发生及抗氧化膳食模式的拮抗作用研究
- 批准号:82160605
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
I型干扰素通过下调FOXO3介导NLRC4/NLRP3激活触发成人Still病炎症风暴的研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
Optimization of electromechanical monitoring of engineered heart tissues
工程心脏组织机电监测的优化
- 批准号:
10673513 - 财政年份:2023
- 资助金额:
$ 67.61万 - 项目类别:
The RaDIANT Health Systems Intervention for Equity in Kidney Transplantation
Radiant 卫生系统干预肾移植的公平性
- 批准号:
10681998 - 财政年份:2023
- 资助金额:
$ 67.61万 - 项目类别:
Regulation of human tendon development and regeneration
人体肌腱发育和再生的调节
- 批准号:
10681951 - 财政年份:2023
- 资助金额:
$ 67.61万 - 项目类别:
Toward Accurate Cardiovascular Disease Prediction in Hispanics/Latinos: Modeling Risk and Resilience Factors
实现西班牙裔/拉丁裔的准确心血管疾病预测:风险和弹性因素建模
- 批准号:
10852318 - 财政年份:2023
- 资助金额:
$ 67.61万 - 项目类别:
The impact of Medicaid expansion on the rural mortality penalty in the United States
医疗补助扩大对美国农村死亡率的影响
- 批准号:
10726695 - 财政年份:2023
- 资助金额:
$ 67.61万 - 项目类别: